Efficacy and safety of a single switch from etanercept originator to etanercept biosimilar in a cohort of inflammatory arthritis

HIGHLIGHTS

  • who: Maria Chiara Ditto from the DepartmentUniversity of have published the Article: Efficacy and safety of a single switch from etanercept originator to etanercept biosimilar in a cohort of inflammatory arthritis, in the Journal: Scientific Reports Scientific Reports of 30/07/2019
  • what: The aim of this work is to evaluate the disease activity trend after switching from etanercept originator Enbrel (oETA) to its biosimilar SB4/Benepali (bETA) in a population admitted to Città della Scienza e della Salute Hospital in Turin, Piedmont, Italy.

SUMMARY

    In Italy, the Italian competent authority . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?